Pyruvate-GPR31 axis induces LysoDC dendrite protrusion to M-cell pockets for effective immune responses

Katsuhiro Nakanishi1, Takayuki Ajiro1, Kaito Yukishima1

  • 1Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

Gut Microbes
|August 1, 2025
PubMed

Insights

Bacterial pyruvate enhances intestinal immunity by activating lysozyme-expressing dendritic cells (LysoDCs) via G-protein coupled receptor 31 (GPR31). This boosts pathogen clearance and T cell responses, conferring resistance to infection.

Area of Science:

  • Immunology
  • Microbiology
  • Gastroenterology

Background:

  • Peyer's patches (PPs) are key for intestinal immunity, but antigen capture by underlying phagocytes is poorly understood.
  • Microfold (M) cells in PPs transfer pathogens, but downstream immune cell activation mechanisms require elucidation.

Purpose of the Study:

  • To investigate the role of bacterial metabolites in modulating antigen capture by mononuclear phagocytes in Peyer's patches.
  • To elucidate the mechanism by which pyruvate influences dendritic cell function and intestinal immunity.

Main Methods:

  • Administration of pyruvate to wild-type and GPR31-deficient mice orally infected with Listeria monocytogenes.
  • Analysis of dendritic cell morphology, antigen uptake, gene expression, and migration patterns.
  • Assessment of T cell responses (Th1, cytotoxic T cells) and host resistance to infection.

Main Results:

  • Pyruvate induced specific dendritic cell (LysoDC) protrusions into M-cell pockets via GPR31.
  • Pyruvate enhanced LysoDC uptake of Listeria monocytogenes in a GPR31-dependent manner.
  • GPR31 signaling boosted antigen processing, altered gene expression, promoted LysoDC migration, and enhanced pathogen-specific T cell responses.

Conclusions:

  • The pyruvate-GPR31 axis is crucial for orchestrating intestinal protective immunity.
  • Pyruvate administration confers significant resistance to Listeria monocytogenes infection via GPR31-mediated immune activation.
  • This study reveals a novel mechanism for bacterial metabolite-driven immune modulation in the gut.